
Lafiya is the UK Government’s flagship health systems strengthening and reform programme in Nigeria, funded by the Foreign, Commonwealth and Development Office (FCDO) and delivered by Palladium. Running from 2020 to 2028, it provides embedded technical assistance to federal, state and local institutions to accelerate sustainable reform and improve outcomes for Nigeria’s most vulnerable populations.
The programme operates at federal level, in the Federal Capital Territory, and across five priority states: Kaduna, Kano, Jigawa, Borno and Yobe. It supports 138 Local Government Areas and has three overarching objectives: to catalyse Nigeria’s political and financial commitment to health, especially for the poorest; strengthen upstream systems for basic health and nutrition services; and increase uptake of modern contraceptives among women of reproductive age.
Lafiya’s defining feature is its politically informed, embedded approach, which translates national policy into effective state-level implementation. It is aligned with government priorities, including the Health Sector Wide Approach, Annual Operational Plans, budgets and the HOPE PHC reform agenda, and works with financing mechanisms such as HOPE PHC and BHCPF 2.0 to unlock sustainable health financing at scale. The programme scope from April 2026 to September 2028 is organised around five output areas:
Cross‑cutting priorities, SRHR, nutrition, health security, climate adaptation, and resilience are integrated throughout, ensuring reforms deliver inclusive and sustainable health outcomes.
The Lafiya Programme supports strengthened governance, sustainable health financing, and resilient health systems in Nigeria. Antimicrobial Resistance (AMR) is a growing cross-sectoral challenge that impacts health security, healthcare quality, livestock production, food safety, environmental health, and economic development, requiring coordinated One Health action.
Nigeria's National Action Plan on AMR (2024-2028) and investments from the Fleming Fund and other partners have strengthened AMR coordination, surveillance, laboratory systems, stewardship, and policy development. Sustaining and scaling these gains, however, requires stronger government ownership, enhanced institutional accountability, improved integration of AMR into planning and budgeting processes, and more effective partner coordination.
To inform future programming, Lafiya seeks a rapid Political Economy Analysis (PEA) of AMR in Nigeria. Building on existing AMR, Fleming Fund, sustainability, and stakeholder evidence, the analysis will examine the political, institutional, and financing factors that influence AMR prioritisation, resource allocation, coordination, and implementation. It will identify practical opportunities to strengthen government-led AMR financing, governance, and multisectoral action within the broader context of health security, primary healthcare, universal health coverage, food safety, and agricultural development.
The consultancy will undertake a rapid Political Economy Analysis (PEA) of Antimicrobial Resistance (AMR) in Nigeria to generate strategic insights that inform future AMR financing, governance, and stakeholder engagement. The analysis will identify the political, institutional, and financial factors that shape AMR prioritization, resource allocation, coordination, and implementation, and provide practical recommendations to strengthen sustainable government-led action.
Reports to: The AMR PEA Consultant will report directly to the Lafiya National Team Leader
Duration: The consultancy will run from October 2026 to January 2027
The consultant will undertake a rapid, politically informed One Health Political Economy Analysis (PEA) to identify the institutional, financial, and stakeholder dynamics influencing AMR prioritization, financing, and implementation in Nigeria. Key responsibilities will include:
S/NSpecific Activity Expected Outputs 1Inception and analytical framework Inception report; refined questions and scope; methodology; stakeholder map and interview plan; document request; workplan; risk and ethics protocol 2 Desk review and evidence-gap analysis Desk-review synthesis; evidence matrix; preliminary hypotheses; map of relevant policies, plans, budgets, costing, transition and handover materials 3 Stakeholder consultations and process tracing Interview records/secure notes; updated stakeholder and influence map; selected decision/process traces; emerging-findings memo 4 Political economy and financing analysis Institutional and incentive analysis; budget and financing pathway analysis; competition/complementarity analysis; preliminary entry points 5 Draft report and decision products Draft PEA report; draft executive summary; draft financing, governance and partner-engagement recommendations; presentation deck 6 Dissemination and validation workshop Workshop agenda and materials; facilitation of one dissemination/validation workshop; participant feedback; workshop report and recommendation/action matrix 7 Finalization Final PEA report; 4–6 page policy brief; final presentation deck; stakeholder/partner engagement roadmap; anonymised evidence annex and final action matrix
Employment Type: Consultancy
Compensation Type: Daily
Our company provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, sex, national origin, age, disability or genetics.

Climate change. Conflict. Inequality. Palladium works with governments, businesses, investors, and communities to solve the world’s most pressing challenges. Our clients trust us to design and implement complex, large-scale programs in any environment, creating lasting impact where it’s needed most.
Founded in 1965 and operating in 100 countries, Palladium is on a mission to be the most impactful business on the planet. www.thepalladiumgroup.com